Abstract
Background
Effective mass drug administration (MDA) is the cornerstone in the elimination of lymphatic filariasis (LF) and a critical component in combatting all neglected tropical diseases for which preventative chemotherapy is recommended (PC-NTDs). Despite its importance, MDA coverage, however defined, is rarely investigated systematically across time and geography.
Most commonly, investigations into coverage react to unsatisfactory outcomes and tend to focus on a single year and health district. Such investigations omit more macro-level influences including sociological, environmental, and programmatic factors.
The USAID NTD database contains measures of performance from thousands of district-level LF MDA campaigns across 14 years and 10 West African countries. Specifically, performance was measured as an MDA’s epidemiological coverage, calculated as persons treated divided by persons at risk.
This analysis aims to explain MDA coverage across time and geography in West Africa using sociological, environmental, and programmatic factors.
Methodology
The analysis links epidemiological coverage data from 3,880 LF MDAs with contextual, non-NTD data via location (each MDA was specific to a health district) and time (MDA month, year). Contextual data included rainfall, temperature, violence or social unrest, COVID-19, the 2014 Ebola outbreak, road access/isolation, population density, observance of Ramadan, and the number of previously completed MDAs.
Principal findings
We fit a hierarchical linear regression model with coverage as the dependent variable and performed sensitivity analyses to confirm the selection of the explanatory factors.
Above average rainfall, COVID-19, Ebola, violence and social unrest were all significantly associated with lower coverage. Years of prior experience in a district and above average temperature were significantly associated with higher coverage.
Conclusions/Significance
These generalized and context-focused findings supplement current literature on coverage dynamics and MDA performance. Findings may be used to quantify typically anecdotal considerations in MDA planning. The model and methodology are offered as a tool for further investigation.
Funder
United States Agency for International Development
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference37 articles.
1. Global programme to eliminate lymphatic filariasis: progress report, 2020 –Programme mondial pour l’élimination de la filariose lymphatique: rapport de situation, 2020.;World Health Organization = Organisation mondiale de la Santé;Wkly Epidemiol Rec Relevé Épidémiologique Hebd.,2021
2. Strategies and tools for the control/elimination of lymphatic filariasis;EA Ottesen;Bull World Health Organ,1997
3. Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.;WA Stolk;Filaria J.,2006
4. A campaign of “communication for behavioural impact” to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people’s knowledge and treatment coverage.;KD Ramaiah;Ann Trop Med Parasitol,2006
5. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review;BV Babu;Trans R Soc Trop Med Hyg,2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献